When Canada legalized the recreational use of cannabis in 2018, locally headquartered HEXO Corp (HEXO) saw an opportunity to transform the company from a medical marijuana producer into one of the largest adult-use cannabis companies in the country.
For licensed producers such as HEXO, legalization unleashed an opportunity to introduce new smokeless cannabis products such as oral sprays, softgel capsules, vape pens and edibles, in addition to carefully cultivated cannabis strains aimed at providing users a variety of effects.
To be successful in this new industry, HEXO knew it had to be proactive in securing a strategic portfolio of intellectual property (IP) assets – including patents, trade secrets, trademarks and copyrights.